Sunmax Biotechnology Co (4728.TWO) Osake Kurssi

Sunmax Biotechnology Co Ltd is a company based in Tainan, Taiwan, operating within the Health Care sector, specifically in the Biotechnology industry. Founded through an IPO on January 25, 2010, the company employs 37 people. It develops, manufactures, and commercializes medical devices, biomedical materials, and bio-surgical products. The company's product range includes collagen, collagen implants, microfiber collagen hemostat, collagen absorbable hemostat pads, healthcare products, and medical collagen application equipment. These products are utilized in both medical and beauty care industries. Sunmax Biotechnology distributes its products primarily within Taiwan, Mainland China, and other regions. The company maintains a website at https://www.sunmaxbiotech.com/ for further information. Its headquarters are located in Tainan, Taiwan, and it is listed on the Taiwan Stock Exchange under the ticker 4728.TWO with ISIN TW0004728001. The company's activities focus on the development and application of collagen-based technologies for medical and cosmetic purposes.